New York-based PE firm SK Capital Partners, which invests across the specialty materials, ingredients and life sciences industries, has closed SK Capital Partners VI (Fund VI), the latest vintage of its flagship private investment strategy, with $2.95bn in total capital commitments.
In a press statement, Barry Siadat, Co-Founder and Managing Director at SK Capital Partners, said: “SK Capital has one of the largest and longest-standing teams dedicated to the sectors in which we invest.
